USPTO serial 79282299
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $425
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 30, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 28, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 13, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 28, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 28, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 1, 2020 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Sep 1, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 16, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 27, 2020 | NPUB | NOTICE OF PUBLICATION | — |
| May 13, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 7, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 11, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 7, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 6, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 2, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |